Codexis, Inc. (CDXS)
Nasdaq: CDXS · Industrial Organic Chemicals · Redwood City, CA · filing with the SEC since 2002
Who owns Codexis, Inc.
As filed with the SECHolders of 5% or more
6
Opaleye Management Inc. holds 7.47% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed May 5, 2026 says.
Directors and officers
12
report now, of 28 people on the record since 2010. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Opaleye Management Inc.
SCHEDULE 13G/A · filed May 5, 2026 · Common Stock, par value $0.0001 per share · 7.52% in Jan 23, 2026
Aberdeen Group plc
SCHEDULE 13G/A · filed Jul 20, 2026 · Common Stock, par value $0.0001 per share · 8.82% in Jan 15, 2026
Telemark Asset Management, LLC
SCHEDULE 13G · filed Jul 29, 2026 · Common Stock, par value $0.0001 per share
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 24, 2025 · Common Stock
Lytton Laurence W
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · 5% in Mar 11, 2026
Integrated Core Strategies (US) LLC
SCHEDULE 13G · filed Apr 14, 2026 · Common Stock, par value $0.0001 per share
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Nov 14, 2024 · Common Stock, par value $0.0001 per share · reported falling below 5%
Fmr LLC
SCHEDULE 13G/A · filed Nov 5, 2025 · COMMON STOCK · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
Casdin Capital, LLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 8.7% in Aug 14, 2025
What CDXS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Cantor
An entity · legal entity · owns, named in the 10-K filed Mar 11, 2026
Seq Well
An entity · legal entity · owns, named in the 10-K filed Mar 11, 2026
Molecular Assemblies, Inc.
An investee · investee · invested in, named in the 10-K filed Mar 11, 2026
Insider tradesForm 4
11sales
0purchases
0sales on a scheduled plan
5people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | 23 | $6.6M | 0 | 0 | $0 |
| Moore Alison | President and CEO | 2 | $0 | 0 | 0 | $0 |
| Lutz Stefan | Chief Scientific Officer | 3 | $0 | 0 | 0 | $0 |
| Erbez Georgia | See Remarks | 2 | $0 | 0 | 0 | $0 |
| De Vre Raymond | director | 3 | $0 | 0 | 0 | $0 |
| Wolf Dennis P | director | 1 | $0 | 0 | 0 | $0 |